Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
276 result(s)
Ellipta inhaler
27-11-2015
Ellipta inhaler information for UK healthcare prpfessionals including getting started, how to use the Ellipta inhaler and top tips for your patients.
Incruse▼ Ellipta
21-11-2015
Incruse▼ (umeclidinium bromide inhalation powder) product information and resources to support UK healthcare professionals in their daily practice.
Sitemap
GlaxoSmithKline (GSK) UK healthcare professional website site map.
DECTOVA
Zanamivir IV</br> Influenza
Supply
Information to be provided to Healthcare Professionals on GSK’s medicines and vaccines supply availability
Dectova
Zanamivir IV<br/> Influenza
Dectova
Zanamivir IV<br/> Influenza
Falsified Medicines Directive
Information to support UK healthcare professionals on the falsified medicines directive in relation to GSK medicines and vaccines.
Homepage
GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.
Therapy areas
GSK UK therapy areas page allows healthcare professionals to find GSK product information by therapy area.
COPD expert perspectives
Watch GSK Global Medical Experts approach key issues in COPD treatment, offering solutions for UK healthcare professionals.
COPD
Overview of COPD
Commissioning
Resources to support commissioners and healthcare professionals when making an asthma or COPD formulary application.
Planning and Implementation
Information to support commissioners and healthcare professionals plan and implement an Ellipta asthma or COPD guidelines.
Setting the record straight
Read about why we (GSK) share our trials results regardless of whether they reflect positively or negatively on our medicines.
ERS 2018
Watch video highlights from this year's ERS Conference
Respiratory
Overview of Asthma and COPD
Asthma expert perspectives
Watch GSK Global Medical Experts approach key issues in asthma treatment, offering potential solutions for you and your patients
Asthma
Overview of Asthma
Severe Asthma
Overview of severe asthma
Ellipta critical error studies in asthma
Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their asthma patients
Ellipta critical error studies in COPD
Information about the benefits of GSK's Ellipta inhaler for UK healthcare professionals to support their COPD patients
Expert Perspectives | Ellipta device | Respiratory | GSKpro
webpage to host device related video content from webinars
Healthcare in your pocket
Healthcare in your pocket - Read about the work GSK is involved in with digital technology such as the development of apps like MyAsthma.
Vaccines
GSK UK information about our vaccines and disease awareness campaigns
Vaccines – frequently asked questions
Answers to frequently asked questions about GSK Vaccines
Ordering and delivery
Find out how to set up an account and start ordering GSK vaccines.
Seretide Accuhaler and Ventolin Accuhaler recall
Seretide Accuhaler and Ventolin Accuhaler product recall information for UK healthcare professionals
Contact us
GSK UK contact page for healthcare professionals
Request a contact
Contact us form for UK healthcare professionals to contact GSK
Report Adverse Event
Form for UK healthcare professionals to report an adverse event related to a GSK product
device
Avamys dosage and device: device image with features and benefits, how to use video, preferred and improved experience over MFNS, comparison video
guidelines
Avamys guidelines: recommendations from ARIA 2016, AAOHNS 2015, BSACI 2017, AAAAI/ACAAI 2017; BSACI 2017 algorithm; treatment algorithm in children
Avamys Overview
Avamys topic index: request, indications, patients, device, efficacy, action, guidelines
safety
Avamys safety in adults and children: well-tolerated, common AE, bioavailability, rapid clearance, no mucosal atrophy, no effect on lower leg growth rate
management-of-AR
Avamys Videos: Avamys device, patient preference study, AR management, efficacy
videos
Avamys Videos: Avamys device, patient preference study, AR management, efficacy
efficacy
Avamys efficacy: nasal and ocular symptoms reduction, targeted action, tissue retention, PD profile video
indication
Avamys indications: adult patients with moderate-to-severe perennial AR, seasonal AR, and moderate AR with asthma; pediatric patient
COPD Guidelines and Guidance
Incruse▼ (umeclidinium bromide inhalation powder) COPD guidance and guidelines to support UK healthcare professionals in their daily practice.
Indications
Incruse▼ (umeclidinium bromide inhalation powder) indication information to support UK healthcare professionals in their daily practice.
Guidelines
This page is currently under review.
Toctino▼
Toctino (alitretinoin) information and resources to support UK healthcare professionals in their daily practice.
Living with severe chronic hand eczema
This page is currently under review.
Pregnancy prevention programme
Toctino (alitretinoin) pregnancy prevention programme information and resources to support UK healthcare professionals in their daily practice.
Products
GSK product information for UK healthcare professionals
Administration and storage
Varilrix – Chickenpox/varicella vaccine administration and storage information to support UK healthcare professionals
Indications and dosage
Varilrix – Chickenpox/varicella vaccine indications and dosage information to support UK healthcare professionals
Efficacy and effectiveness
Varilrix – Chickenpox/varicella vaccine efficacy and effectiveness information to support UK healthcare professionals
Varilrix
Varilrix – Chickenpox/varicella vaccine product information to support UK healthcare professionals
Safety
Varilrix – Chickenpox/varicella vaccine safety information to support UK healthcare professionals
Mode of action
Bexsero Meningitis B vaccine mode of action information for UK healthcare professionals
Invasive Meningococcal Disease
Bexsero Meningitis B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD)
Epidemiology
Bexsero Men B vaccine information for healthcare professionals about Invasive Meningococcal Disease (IMD) epidemiology
Transmission and symptoms
Bexsero Meningitis B vaccine transmission and symptoms information for UK healthcare professionals
Bexsero
Bexsero Meningitis B vaccine information for UK healthcare professionals
Bexsero Overview
Bexsero Meningitis B vaccine overview for UK healthcare professionals
List price reduction
Learn about the list price reductions on some packs of the Seretide range
Clinical evidence
Clinical evidence to support UK Healthcare professionals in the use of Seretide for asthma and COPD.
Seretide in younger patients
Find out how Seretide could be used to treat the symptoms of asthma in paediatric patients aged four and above.
Why Seretide?
Find out about the benefits of prescribing Seretide for your asthma/COPD patients.
Seretide inhaler technique and safety
Videos and materials to help you ensure your patients are using their Seretide Accuhaler and Evohaler correctly.
Seretide rebates and savings
Learn about the immediate savings you could make by signing up to our Seretide rebate.
Adartrel
Adartrel (ropinirole hydrochloride) - links to the summary of product characteristics, patient information leaflet and supply information to support UK healthcare professionals.
How to prescribe
An overview of Duac 5% and Duac 3% formulation, strength, indications and how to prescribe Duac
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Guidelines
An overview of the EDF guideline recommendations and the role of Duac in the treatment of acne
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Duac (clindamycin / benzoyl peroxide) | Dermatology | GSK Pro
Duac (clindamycin / benzoyl peroxide) information to support UK healthcare profesionals
Augmentin Duo
Information on the discontinuation of Augmentin Duo Strawberry Flavour and the replacement of Augmentin Duo Mixed Fruit Flavour
Trelegy▼ Ellipta
Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) product information & resources to support UK healthcare professionals in their daily practice.
Efficacy and safety
Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) efficacy and safety information to support UK healthcare professionals.
Quality of Life (IMPACT)
Health-related QoL efficacy results for TRELEGY Ellipta
Efficacy
Trelegy Ellipta is a Triple Therapy indicated for maintenance treatment in adult patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an ICS and a LABA.
Lung Function (IMPACT)
Lung Function efficacy results for TRELEGY Ellipta
Exacerbations (IMPACT)
Exacerbation efficacy results for TRELEGY Ellipta.
Formulary support
Trelegy▼ Ellipta (fluticasone furoate / umeclidinium / vilanterol) formulary support information to support UK healthcare professionals.
Zovirax
Information on the discontinuation of Zovirax (aciclovir) eye ointment 3% 4.5g for UK healthcare professionals
AeroChamber Plus
The distribution of AeroChamberPlus* has transferred from GSK UK Ltd to Trudell Medical UK as of 21st December 2017.
Amoxil
Information on the discontinuation of Amoxil and Amoxil capsules for UK healthcare professionals
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
Show more
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.
